1. 1326PEvaluation of the efficacy and safety of everolimus as a first-line treatment in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors. (23rd October 2018) Authors: Koumarianou, A; Pectasides, D G; Manousou, K; Dionysopoulos, D; Kaltsas, G A; Kolomodi, D; Poulios, C; Skondra, M; Samantas, E; Pentheroudakis, G; Fountzilas, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 677PAfatinib in combination with cisplatin and 5-fluorouracil (5-FU) as first line treatment in inoperable gastric and gastro-esophageal junction (GEJ) cancer: A phase II study by the Hellenic Cooperative Oncology Group. (23rd October 2018) Authors: Makatsoris, T; Samantas, E; Manousou, K; Karavasilis, V; Aravantinos, G; Tryfonopoulos, D; Psyrri, A; Pectasides, D G; Pazarli, E; Petraki, C; Tsipoura, A; Kaklamanos, I G; Fountzilas, G; Pentheroudakis, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗